| Pharmaceutical Information |
| Drug Name |
Lormetazepam |
| Drug ID |
BADD_D01321 |
| Description |
Lormatazepam is an orally available benzodiazepine used in the UK for the treatment of short-term insomnia [L927]. It is marketed by Auden Mckenzie (Pharma Division) in 0.5 and 1 mg tablet formulations. |
| Indications and Usage |
For the treatment of short-term insomnia [L927] |
| Marketing Status |
Not Available |
| ATC Code |
N05CD06 |
| DrugBank ID |
DB13872
|
| KEGG ID |
D01657
|
| MeSH ID |
C023842
|
| PubChem ID |
13314
|
| TTD Drug ID |
D0I8HJ
|
| NDC Product Code |
12828-0021 |
| Synonyms |
lormetazepam | methyllorazepam |
|
| Chemical Information |
| Molecular Formula |
C16H12Cl2N2O2 |
| CAS Registry Number |
848-75-9 |
| SMILES |
CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3Cl |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
